Sort
40,608 grants matching “prostate cancer”
MYOSIN VI FUNCTION AND MECHANISM
$342,000Kathryn G Miller · Washington University · R01 · FY2009 · GM
MeritCare Hospital Community Clinical Oncology Program
$342,000Roger Maris Cancer Center · U10 · FY2004 · CA
MOLECULAR MECHANISMS OF METASTASIS
$341,996Childrens Hospital Of Philadelphia · R01 · FY2004 · CA
iMRI Methods for Cancer Diagnosis and Treatment
$341,991Stanford University · R01 · FY2004 · CA
Target MIC shedding to revive anti-tumor immunity
$341,981Jennifer D Wu · Medical University Of South Carolina · R01 · FY2016 · CA
Target MIC shedding to revive anti-tumor immunity
$341,981Jennifer D Wu · Northwestern University At Chicago · R01 · FY2017 · CA
PET Imaging of Tumor Targeting & Role of T Lymphocytes
$341,948Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
PET Imaging of Tumor Targeting & Role of T Lymphocytes
$341,948Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
DELINEATING THE REGULATORY NETWORK OF MASTER TRANSCRIPTION FACTORS IN PROSTATE CANCER
$341,919Northwestern University · · FY2009 · Department of Defense
RANKL and BMPs in Prostate Cancer Induced Bone Lesions
$341,908University Of California Los Angeles · R01 · FY2004 · CA
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
$341,879Scott D Cramer · University Of Colorado Denver · R01 · FY2017 · CA
PDGF D and Prostate Cancer Bone Metastasis
$341,864Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2019 · CA
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer
$341,833Phuoc T. Tran · Johns Hopkins University · R01 · FY2015 · CA
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC
$341,767Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2021 · CA
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC
$341,767Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2020 · CA
Role of small molecule interactions and multiprotein assemblies in CYP1B1 disease-associated function and dysfunction
$341,760Edith C Glazer · University Of Kentucky · R01 · FY2020 · GM
Regulation of the tumor suppressor PTEN
$341,760Burnham Institute For Medical Research · R01 · FY2003 · CA
Pathobiology and Mechanism of Progesterone Resistance in Human Endometrial Cancer
$341,706Sanaz Memarzadeh · University Of California Los Angeles · R01 · FY2019 · CA
Radiotherapy-induced tumor immunity
$341,706Dorthe Schaue · University Of California Los Angeles · R01 · FY2019 · CA
Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor
$341,681Paul Robustelli · Dartmouth College · R35 · FY2021 · GM
GENETIC STUDIES OF GOOD HEALTH IN AN AGING TWIN COHORT
$341,670Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2000 · AG
Ultrasensitive PSA Quantitation Using Smartphone to Reduce Prostate Cancer Monitoring Disparities
$341,668Ping Wang · Instanosis, Inc. · R41 · FY2022 · CA
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
$341,664Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Adaptive resistance to HIF1a inhibition in hypoxia
$341,648Zheng David Qian · Oregon Health & Science University · R01 · FY2019 · CA
Neural Progenitor Cells as Cancer Therapy Vectors
$341,584Karen S Aboody · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA